4QL1

Crystal structure of human WDR5 in complex with compound OICR-9429


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.5 Å
  • R-Value Free: 0.227 
  • R-Value Work: 0.195 

wwPDB Validation 3D Report Full Report


This is version 1.4 of the entry. See complete history

Literature

Pharmacological targeting of the Wdr5-MLL interaction in C/EBP alpha N-terminal leukemia.

Grebien, F.Vedadi, M.Getlik, M.Giambruno, R.Grover, A.Avellino, R.Skucha, A.Vittori, S.Kuznetsova, E.Smil, D.Barsyte-Lovejoy, D.Li, F.Poda, G.Schapira, M.Wu, H.Dong, A.Senisterra, G.Stukalov, A.Huber, K.V.Schonegger, A.Marcellus, R.Bilban, M.Bock, C.Brown, P.J.Zuber, J.Bennett, K.L.Al-Awar, R.Delwel, R.Nerlov, C.Arrowsmith, C.H.Superti-Furga, G.

(2015) Nat.Chem.Biol. 11: 571-578

  • DOI: 10.1038/nchembio.1859

  • PubMed Abstract: 
  • The CEBPA gene is mutated in 9% of patients with acute myeloid leukemia (AML). Selective expression of a short (30-kDa) CCAAT-enhancer binding protein-α (C/EBPα) translational isoform, termed p30, represents the most common type of CEBPA mutation in ...

    The CEBPA gene is mutated in 9% of patients with acute myeloid leukemia (AML). Selective expression of a short (30-kDa) CCAAT-enhancer binding protein-α (C/EBPα) translational isoform, termed p30, represents the most common type of CEBPA mutation in AML. The molecular mechanisms underlying p30-mediated transformation remain incompletely understood. We show that C/EBPα p30, but not the normal p42 isoform, preferentially interacts with Wdr5, a key component of SET/MLL (SET-domain/mixed-lineage leukemia) histone-methyltransferase complexes. Accordingly, p30-bound genomic regions were enriched for MLL-dependent H3K4me3 marks. The p30-dependent increase in self-renewal and inhibition of myeloid differentiation required Wdr5, as downregulation of the latter inhibited proliferation and restored differentiation in p30-dependent AML models. OICR-9429 is a new small-molecule antagonist of the Wdr5-MLL interaction. This compound selectively inhibited proliferation and induced differentiation in p30-expressing human AML cells. Our data reveal the mechanism of p30-dependent transformation and establish the essential p30 cofactor Wdr5 as a therapeutic target in CEBPA-mutant AML.


    Organizational Affiliation

    CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna 1090, Austria.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
WD repeat-containing protein 5
A, B
312Homo sapiensMutation(s): 0 
Gene Names: WDR5 (BIG3)
Find proteins for P61964 (Homo sapiens)
Go to Gene View: WDR5
Go to UniProtKB:  P61964
Small Molecules
Ligands 4 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
35Q
Query on 35Q

Download SDF File 
Download CCD File 
A, B
N-(4-(4-methylpiperazin-1-yl)-3'-(morpholinomethyl)-[1,1'-biphenyl]-3-yl)-6-oxo-4-(trifluoromethyl)-1,6-dihydropyridine-3-carboxamide
C29 H32 F3 N5 O3
DJOVLOYCGXNVPI-UHFFFAOYSA-N
 Ligand Interaction
GOL
Query on GOL

Download SDF File 
Download CCD File 
B
GLYCEROL
GLYCERIN; PROPANE-1,2,3-TRIOL
C3 H8 O3
PEDCQBHIVMGVHV-UHFFFAOYSA-N
 Ligand Interaction
UNX
Query on UNX

Download SDF File 
Download CCD File 
A, B
UNKNOWN ATOM OR ION
X
*
 Ligand Interaction
EDO
Query on EDO

Download SDF File 
Download CCD File 
B
1,2-ETHANEDIOL
ETHYLENE GLYCOL
C2 H6 O2
LYCAIKOWRPUZTN-UHFFFAOYSA-N
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.5 Å
  • R-Value Free: 0.227 
  • R-Value Work: 0.195 
  • Space Group: P 1
Unit Cell:
Length (Å)Angle (°)
a = 46.843α = 71.45
b = 56.628β = 88.94
c = 64.688γ = 65.43
Software Package:
Software NamePurpose
Cootmodel building
PDB_EXTRACTdata extraction
REFMACrefinement
SCALEPACKdata scaling
MxDCdata collection
HKL-2000data reduction
HKL-2000data scaling
PHASERphasing

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Revision History 

  • Version 1.0: 2014-12-17
    Type: Initial release
  • Version 1.1: 2015-04-15
    Type: Non-polymer description
  • Version 1.2: 2015-07-15
    Type: Database references
  • Version 1.3: 2015-07-29
    Type: Database references
  • Version 1.4: 2016-02-24
    Type: Database references